Editorial: Nephrotic Syndrome in Pediatric Patients

被引：1
|
作者：
Woroniecki, Robert P. [1 ]
Swiatecka-Urban, Agnieszka [2 ,3 ]
Kaskel, Frederick J. [4 ]
机构：
[1] Stony Brook Childrens Hosp, Stony Brook, NY 11794 USA
[2] Childrens Hosp Pittsburgh, Dept Nephrol, Pittsburgh, PA 15213 USA
[3] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA USA
[4] Albert Einstein Coll Med, Childrens Hosp Montefiore, Div Pediat Nephrol, New York, NY USA
来源：
FRONTIERS IN PEDIATRICS | 2017年 / 5卷
关键词：
podocytopathy; APOL; 1; FSGS; calcineurin inhibitor; outcomes; edema; endocytic trafficking; obesity;
D O I：
10.3389/fped.2017.00167
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] EVALUATION OF EPICARDIAL ADIPOSE TISSUE IN PEDIATRIC PATIENTS WITH NEPHROTIC SYNDROME DIAGNOSIS
    Simsek, Ozgur Ozdemir
    DemIrcan, Tulay
    ErfIdan, Gokcen
    Basaran, CemalIye
    Alparslan, Caner
    Camlar, Secil Arslansoyu
    Mutlubas, Fatma
    Demir, Belde Kasap
    Alaygut, Demet
    PEDIATRIC NEPHROLOGY, 2021, 36 (10) : 3363 - 3363
  • [32] RITUXIMAB BIOAVAILABILITY IN PEDIATRIC PATIENTS WITH STEROID DEPENDENT IDIOPATHIC NEPHROTIC SYNDROME
    Parmentier, Cyrielle
    Mignot, Sabine
    Bertrand, Quentin
    Ulinski, Tim
    Dossier, Claire
    PEDIATRIC NEPHROLOGY, 2021, 36 (10) : 3294 - 3294
  • [33] Tacrolimus therapy in pediatric patients with treatment-resistant nephrotic syndrome
    Kim Loeffler
    Manjula Gowrishankar
    Verna Yiu
    Pediatric Nephrology, 2004, 19 : 281 - 287
  • [34] Does rituximab induce hypogammaglobulinemia in patients with pediatric idiopathic nephrotic syndrome?
    Delbe-Bertin, Laetitia
    Aoun, Bilal
    Tudorache, Elena
    Lapillone, Helene
    Ulinski, Tim
    PEDIATRIC NEPHROLOGY, 2013, 28 (03) : 447 - 451
  • [35] Population pharmacokinetics and dosage optimization of tacrolimus in pediatric patients with nephrotic syndrome
    Wang, Xiaoqing
    Hang, Ye
    Chen, Chaoyang
    Ma, Lingyue
    Xiao, Huijie
    Zhou, Ying
    Cui, Yimin
    Wang, Fang
    Su, Baige
    Yao, Yong
    Ding, Jie
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2019, 57 (03) : 125 - 134
  • [36] Use of recombinant human serum albumin in pediatric patients with nephrotic syndrome
    Tsuruga, Kazushi
    Oki, Eishin
    Yashiro, Tomomi
    Ito, Etsuro
    Tanaka, Hiroshi
    PEDIATRIC NEPHROLOGY, 2009, 24 (11) : 2275 - 2276
  • [37] Optimal Trough Concentration of Tacrolimus in Pediatric Patients With Primary Nephrotic Syndrome
    Wang, Hui
    Liu, Maochang
    Wang, Xiaowen
    Peng, Hui
    Niu, Changhe
    Li, Mengting
    Gao, Ping
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2025, 117 (02) : 436 - 444
  • [38] INCREASED PREVALENCE OF ELEVATED LIPOPROTEIN(A) (LP(A)) IN PEDIATRIC-PATIENTS WITH IDIOPATHIC NEPHROTIC SYNDROME (INS) COMPARED TO ADULT NEPHROTIC PATIENTS
    BROWN, CD
    IFUDU, O
    AZROLAN, N
    THOMAS, L
    ZHAO, ZH
    TEJANI, A
    FRIEDMAN, E
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 326 - 326
  • [39] Homeostatic Model Assessment (HOMA) in pediatric patients with nephrotic syndrome receiving tacrolimus
    Govindan, Sukanya
    Singaram, Saravanan
    Prasad, Hemchand Krishna
    Ekambaram, Sudha
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I725 - I726
  • [40] Tacrolimus therapy in pediatric patients with treatment resistant forms of nephrotic syndrome.
    Yiu, VN
    Gowrishankar, M
    Loeffler, K
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 525A - 525A
12345